Cytek Biosciences (CTKB) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$93.3 million.
- Cytek Biosciences' Enterprise Value rose 4252.66% to -$93.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$93.3 million, marking a year-over-year increase of 4252.66%. This contributed to the annual value of -$98.7 million for FY2024, which is 4109.35% up from last year.
- Latest data reveals that Cytek Biosciences reported Enterprise Value of -$93.3 million as of Q3 2025, which was up 4252.66% from -$75.5 million recorded in Q2 2025.
- Over the past 5 years, Cytek Biosciences' Enterprise Value peaked at -$75.5 million during Q2 2025, and registered a low of -$376.8 million during Q3 2021.
- Its 5-year average for Enterprise Value is -$215.0 million, with a median of -$173.6 million in 2024.
- In the last 5 years, Cytek Biosciences' Enterprise Value tumbled by 11949.21% in 2021 and then skyrocketed by 5758.16% in 2025.
- Cytek Biosciences' Enterprise Value (Quarter) stood at -$364.6 million in 2021, then increased by 17.86% to -$299.5 million in 2022, then surged by 44.03% to -$167.6 million in 2023, then soared by 41.09% to -$98.7 million in 2024, then grew by 5.53% to -$93.3 million in 2025.
- Its Enterprise Value stands at -$93.3 million for Q3 2025, versus -$75.5 million for Q2 2025 and -$95.3 million for Q1 2025.